[EN] COMPOUND FOR THE COVALENT ATTACHMENT OF THE CHEMILUMINESCENT PROBE N-(4-AMINOBUTYL)-N-ETHYLISOLUMINOL (ABEI) TO TARGET MOLECULES AND USES THEREOF<br/>[FR] COMPOSÉ POUR LA LIAISON COVALENTE DE LA SONDE CHIMILUMINESCENTE N-(4-AMINOBUTYL)-N-ÉTHYLISOLUMINOL (ABEI) À DES MOLÉCULES CIBLES ET SES UTILISATIONS
申请人:DIASORIN SPA
公开号:WO2012066003A1
公开(公告)日:2012-05-24
The invention relates to a new molecule/reagent family, N-(4-Aminobutyl)-N- ethylisoluminol anhydroglutarate (ABEI anhydroglutarate), for the covalent attachment of the chemiluminescent label N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to nucleophilic group containing molecules, as peptides and proteins, including antibodies, for the generation of labeled probes to be used in chemiluminescence-based immunoassays.
Use of Phthaloylhydrazide Derivatives as Anti-Hypoxic and defensive Agents
申请人:L.I.M.A.D. Limited
公开号:EP0612733A1
公开(公告)日:1994-08-31
The invention concerns the use of phthaloylhydrazide derivatives and their salts as anti-hypoxic and defensive agents, with special focus on the use of 5-aminophthaloylhydrazide and its salts, when administered in high doses.
Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
申请人:L.I.M.A.D. Limited
公开号:EP0617024A1
公开(公告)日:1994-09-28
The invention pertains to use of phthaloylhydrazide derivatives and salts thereof as anti-inflammatory and antitoxic agents in human and veterinary medicine, and it pertains in particular to use of 5-aminophthaloylhydrazide and of the sodium salt thereof.
The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. Preferred protein denaturing agents are detergents and chaotropic substances.
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof
申请人:DiaSorin S.p.A.
公开号:EP2457916A1
公开(公告)日:2012-05-30
The invention relates to a new molecule/reagent family, N-(4-Aminobutyl)-N-ethylisoluminol anhydroglutarate (ABEI anhydroglutarate), for the covalent attachment of the chemiluminescent label N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to nucleophilic group containing molecules, as peptides and proteins, including antibodies, for the generation of labeled probes to be used in chemiluminescence-based immunoassays.